Preclinical Drug Services For Pre-Clinical
-
based in UNITED KINGDOM
Finding rare events: The Lightcast platform is designed to have a high throughput and will be ideally suited to finding one in 10,000 or one in 100,000 ...
-
based in FRANCE
Advice in the preclinical development of new neuro-active compounds. The Neuron Experts team (operational and scientific) provides support and advice in your R&D programs and also in the development of new molecules in specific disease indications. ...
-
Manufactured by Nexelisbased in USA
From Fit-for-Purpose Development to Qualified and Validated Clinical Assays. Nexelis, a Q² Solutions Company, is a leading partner in assay development and technology transfer, with scientific discipline, critical thinking, and agility. Fit-for-purpose assay development on a wide variety of platforms support your small molecule, large molecule, or vaccine program through all phases of ...
-
by elminda Ltd.based in ISRAEL
CNS drugs exhibit the lowest approval success rates due to multiple challenges such as lack of efficacy in early and advanced stages of development, Poor target selection / engagement, poor translation from pre-clinical models and disease heterogeneity. BNA may contribute in CNS research and drug development by adding new objective endpoints, assisting in understanding drug mechanism, identifying ...
-
Manufactured by Alfa Chemistrybased in USA
One of the most important steps in the process of developing a medicine is determining its safety. Alfa Chemistry is dedicated to providing pre-clinical drug research services to support our clients' drug development, pre-clinical and clinical investigations, and assist them in deciding which drug candidates are most worthwhile to pursue in clinical trials. We emphasize pharmacology, ...
-
Manufactured by Exscientiabased in UNITED KINGDOM
Only with continual feedback between experiment and prediction can machine learning models be refined and deliver against complex therapeutic ...
-
Manufactured by Charles Riverbased in USA
Market pressures continue to change the focus and structure of the drug development industry with a heavy emphasis on accelerating preclinical development to move the most efficacious therapies into the clinic. The preclinical drug development journey is rarely straight and often requires course corrections and pivots. ...
-
Manufactured by ClearLight Biotechnologies, Inc.based in USA
Long before your team will experience commercial success with your brand name drug, preclinical drug development activities take center stage. By the time you submit your investigational new drug (IND) application you’ll want to retire as many risks as possible and have confidence that your experimental drug will have its intended effects on the intended to treat population ...
-
based in USA
Device Types: On-body injectors; Autoinjectors; Pen injectors; Prefilled syringes; Insulin pumps; Microneedle array devices; Smart pills; Electroporation-enabled ...
-
Manufactured by Alfa Chemistrybased in USA
Alfa Chemistry has established a drug safety evaluation system that meets international standards. Our experimental studies strictly follow ICH, CFDA, FDA and OECD guidelines, providing our clients with high quality data and fast study cycles for preclinical safety evaluation of drugs. alfa chemistry helps our clients to shorten the experimental time and reduce the cost of new drug development ...
-
Manufactured by Thermo Fisher Scientificbased in USA
Natural killer (NK) cells are innate lymphocytes that kill virally infected or malignant cells. Unlike T cells, NK cells function in an antigen independent manner, responding to anything they perceive as "non-self", including malignant cells. NK cells are an attractive allogeneic immune modulator, as they have a well-known safety profile and lack the potential to cause graft-vs-host disease, a ...
-
by Kumudabased in USA
Innovation. Not just iteration. Disease biology is complex. Innovative integrated approaches are needed to unlock promising disease treatments. Kumuda is a therapeutics company that accelerates and de-risks novel small molecule drug discovery and development by applying an integrated multi-dimensional ...
-
Manufactured by Creative Biolabsbased in CHINA
Microorganisms, also called microbes, are the collective name of all tiny organisms that are invisible to the naked eye. Harmful microorganisms are called pathogenic microorganisms which can cause diseases. Antimicrobial drugs refer to any substance that inhibits and kills pathogenic microorganisms and are used to treat infectious diseases. They can interfere with the life cycle of microorganisms ...
-
Manufactured by Precision NanoSystemsbased in CANADA
Combining disruptive technology platforms with unparalleled genomic medicine development expertise, Precision NanoSystems’ Biopharmaceutical Services accelerates the development of lipid nanoparticle (LNP) formulations and drug products. ...
-
based in USA
One of the challenges in drug discovery and development is miniaturization. Miniaturization is key to automating small molecule discovery, facilitating higher throughput, increasing reliability and accuracy and reducing costs for screening large compound libraries. We have a solid track record in miniaturizing challenging assays to 384- and 1536-well formats for medium to Ultra-High-Throughput ...
-
Manufactured by Ozgene Pty Ltd.based in AUSTRALIA
Knock-in mice have an insertion in a specific locus in order to produce genetically modified mice for customised research purposes. Reporter genes, human genes, related genes from the same organism, or point mutations can be introduced into the protein-coding region of a gene to produce knock-in mice. The difference between the knock-in and knockout approach is that knock-in mouse models are ...
-
Manufactured by Meda BioTech, Inc.based in USA
Meda's Hybrid-Naiioeiigiiieeriiig™ drug delivery platform generates more commercial opportunities than we can pursue independently. Strategic partnering is thereforea critical component of our ability to advance Meda's novel therapeutics programs into clinical developmentand onto the ...
-
by SoBran Inc.based in USA
Our scientific and technical experts assemble customized research programs with attention to your specific project requirements, timelines and budget. To support small animal preclinical toxicology and drug discovery, we offer an expanding range of services that meet GLP and non-GLP compliant in vivo research requirements. Program management is certified to the ISO 9001:2008 standard. ...
-
Manufactured by HemoShear Therapeutics, Inc.based in USA
Using our powerful REVEAL-TxTM drug discovery platform, our scientists are identifying and validating promising approaches to develop novel treatments aiming to extend and improve the quality of life of patients with rare diseases. In our most advanced program, the company is conducting a phase 2 clinical trial of HST5040, an oral small molecule investigational drug for the treatment of patients ...
-
by Oncodesignbased in FRANCE
Establishing proof of concept in preclinical pharmacology is a critical step in the drug discovery process. This is one of the decisive factors in setting the therapeutic indication(s) targeted in clinical models and in the decision to continue a new product through the regulatory preclinical and clinical steps. For more than 25 years, Oncodesign has been a player known for its experience and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you